BioQuest, Inc. and BotMakers
Expand AI Marketing Services with SpeedLeads XL and
MarketScope XL.
Bioquest Corp. and BotMakers,
Inc. are Partnered to Expand AI Marketing Services with SpeedLead
XL and MarketScope XL
Valued at
$3.1 billion
in
2021, the
market
is projected to
surpass $15 billion by 2031
Katy, TX -- November 26, 2024 --
InvestorsHub NewsWire -- BioQuest, Inc. (OTC:
BQST), soon to complete its acquisition
of
BotMakers, Inc., is
excited to announce the launch of two
groundbreaking AI-driven
marketing services: SpeedLeads XL
and MarketScope
XL.
These innovative tools leverage cutting-edge
artificial intelligence to
transform lead generation and advertising,
offering businesses unparalleled insights and engagement
opportunities with high-intent customers.
The
global market for website lead generation solutions has
been
experiencing exponential growth. With a compound
annual growth rate (CAGR) of 17.48%.
In
the U.S. alone, the digital lead generation market
is
expected to reach $3.24
billion by
2023, driven by increasing investment
in
digital marketing and lead generation services.
This expanding market underscores the
critical role of innovative lead generation
technologies, and BioQuest, through BotMakers,
is
positioned to lead the charge.
SpeedLeads XL: Turning Anonymous
Website Visitors into Actionable Leads
SpeedLeads XL identifies anonymous visitors
to
a
company's website, collects their lead data, and immediately
initiates an
AI-generated phone call to engage with
the
lead in
real
time. With access
to a
data co-operative containing over 300+
million B2B and B2C
records, SpeedLeads XL delivers accurate, high-quality
leads directly to
businesses.
Unique Innovation:
BotMakers is
one
of the
first companies to integrate
AI
voice,
SMS, ringless
voicemail, and drip email
into this
type
of live lead service. By combining these technologies, SpeedLeads
XL offers businesses a seamless and highly engaging multi-channel
approach to connect with potential customers.
Key
benefits include:
•
Real-Time Engagement:
Converts anonymous website visits into actionable
leads by initiating automated, personalized phone calls.
•
Enhanced Targeting:
Identifies patterns, such as
multiple
visitors from the
same
company, signaling strong interest in
your
offerings.
•
Affordable Pricing:
Just $10
per call
generated, with a simple $300 activation
fee, making it accessible for businesses of all
sizes.
•
Multi-Channel Outreach:
Combines AI-powered voice calls with SMS, email,
and voicemail to ensure comprehensive engagement.
"SpeedLeads XL bridges the gap between website
activity and direct engagement," said
Tom
Hemingway, CEO of BioQuest. "This service enables
businesses to connect with potential customers at the right moment,
turning curiosity into meaningful conversations. The integration of
our data co-operative and multi-channel
AI
technologies ensures businesses receive reliable,
actionable information to drive conversions."
MarketScope XL: The Next Best
Thing to Knowing Who is
Searching for Your
Services
MarketScope XL takes targeted advertising to the
next level by identifying high-intent buyers and delivering
precision-targeted ad campaigns. With access to more than
200,000 intent signals
per
second, the AI system identifies potential
customers actively searching for specific products or services,
such as CFOs seeking payroll solutions or attendees of niche
industry conventions.
By
analyzing these intent signals, MarketScope XL creates a tailored
audience ready to receive your ads and messages. It's the next best
thing to knowing exactly who is
searching Google or a major search engine for
services like yours.
Key
features include:
•
High-Intent Audience
Identification: AI analyzes real-time intent signals
to
create customized audiences aligned with your
business goals.
•
Omnipresent Ad
Campaigns: Combines exclusive advertising data, Demand
Side
Platform (DSP) access, and Mobile Ad IDs (MAIDs)
to deliver targeted ads to your ideal prospects across multiple
platforms.
•
Seamless Integration:
Creates a sense of omnipresence by ensuring your
brand is
visible to high-intent prospects wherever they are
online.
"MarketScope XL empowers businesses to reach
customers who are already searching for what they offer,"
said Trent
Daniel,
COO
of BioQuest and Co-Founder
of
BotMakers. "With the
combination of AI, real-time data, and
multi-channel outreach, our solutions ensure that businesses have
the tools they need to thrive in
the
rapidly growing lead generation market. MarketScope XL delivers the
precision and timing that make advertising feel truly
personal."
Combining Speed and Precision
for Maximum Results
Together, SpeedLeads XL and MarketScope XL
redefine lead generation and targeted advertising. Businesses can
now engage with leads in
real time
while simultaneously saturating their target
market with precision advertising, creating a cohesive and
effective marketing strategy.
Both
services will become part of BioQuest's growing portfolio of
AI-powered offerings upon completion of its acquisition of
BotMakers, Inc.
About BioQuest,
Inc.
BioQuest, Inc. (OTC: BQST)
is
a
forward-looking company dedicated to acquiring and advancing
innovative technologies. With its impending acquisition of
BotMakers, Inc., BioQuest aims to deliver cutting-edge AI solutions
to businesses across industries, empowering them to thrive
in
a
rapidly evolving marketplace. Tom Hemingway
is
the
CEO.
Contact:
Tom
Hemingway, CEO bioquest@botmakers.ai
www.bioquestcorp.com
Follow our X account: @bioquestcorp
About BotMakers,
Inc.
BotMakers, Inc. is
a
leader in
AI-driven marketing and engagement solutions,
specializing in
conversational AI
and
automated outreach technologies. Its services, including SpeedLeads
XL and MarketScope XL, empower businesses to streamline customer
interactions, optimize lead generation, and execute high-precision
advertising campaigns.
Contact: S. Hall
aicallers@botmakers.ai
aitestdrive.us botmakers.ai
Forward-Looking
Statements
This
press release contains forward-looking statements within the
meaning of the
Private Securities Litigation Reform Act of
1995.
These forward-looking statements are based on
current expectations, estimates, projections, and assumptions made
by management. Words such as
"expects," "anticipates," "intends," "plans,"
"believes," "seeks," and similar expressions are intended to
identify such forward-looking statements. Forward-looking
statements are subject to risks and uncertainties that could cause
actual results to differ
materially from those expressed or implied
in
such
statements. Such risks and uncertainties include, but are
not
limited to, the ability to successfully integrate
the acquisition, execute the growth strategy, raise the necessary
funds through the planned Reg A offering, and the general economic
conditions affecting the AI
industry. BioQuest Corp. undertakes no obligation
to publicly update or revise any forward-looking statements,
whether as a result of
new
information, future events, or otherwise, except as required by
law. For additional information on the risks and uncertainties that
could affect BioQuest Corp.'s future results, please review the
company's filings with the Securities and Exchange Commission
(SEC), including its Annual Report on Form
10-K,
Quarterly Reports on Form 10-Q, and Current
Reports on Form 8-K.
